Dr. William DeRosa Discusses Nab-Paclitacel in Non-Small Cell Lung Cancer

William T. DeRosa, DO, medical oncologist, Carol G. Simon Cancer Center at Morristown Memorial Hospital, discusses subset analyses from the phase III CA031 trial that examined nab-paclitaxel (Abraxane) in non-small cell lung cancer (NSCLC).

For more information about the CA031 trial and the FDA approval of nab-paclitaxel in lung cancer, visit http://www.onclive.com/web-exc....lusives/FDA-Approves

• Kategori